Renaissance Technologies - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$2,937,000
+322.6%
5,758,391
+17.6%
0.00%
+300.0%
Q4 2016$695,000
+3.4%
4,896,391
+52.9%
0.00%0.0%
Q3 2016$672,000
+13.5%
3,201,993
+35.9%
0.00%0.0%
Q2 2016$592,000
+6.5%
2,355,593
+39.7%
0.00%0.0%
Q1 2016$556,000
+20.9%
1,685,795
+33.1%
0.00%0.0%
Q4 2015$460,000
+6.0%
1,266,400
+51.6%
0.00%0.0%
Q3 2015$434,000
+24.0%
835,400
+45.0%
0.00%0.0%
Q2 2015$350,000
+65.1%
576,100
+98.8%
0.00%
Q1 2015$212,000
+96.3%
289,800
+87.0%
0.00%
Q4 2014$108,000154,9860.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$54,0000.03%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 200,000$73,0000.02%
Benin Management CORP 83,000$30,0000.02%
TWO SIGMA SECURITIES, LLC 36,129$13,0000.02%
NIXON PEABODY TRUST CO 10,000$4,0000.00%
Advisory Services Network, LLC 23,000$8,0000.00%
Sheaff Brock Investment Advisors, LLC 69,500$25,0000.00%
First Heartland Consultants, Inc. 21,500$8,0000.00%
INVESTMENT CENTERS OF AMERICA INC 10,000$4,0000.00%
Renaissance Technologies 1,266,400$460,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders